Carl Icahn
Carl Icahn is a billionaire financier, ranking #18 on the 2007 Forbes 400 list with an estimated net worth of $14.5 billion.
Icahn built a name for himself in the 1980s as a corporate raider. After keeping quite for years, Icahn made a major comeback as a 'activist investor'. An activist investor agitates companies for changes, including buyouts, share buybacks, and dividend increases.
Icahn has successfully pushed for changes at Time Warner (NYSE: TWX) and Temple-Inland (NYSE: TIN), among others. Icahn won board seats at Motorola (NYSE: MOT) after first failing.
In 2007, Icahn's activism successfully pushed biotech company MedImmune into a sales agreement with AstraZeneca (NYSE: AZN). Icahn is also involved with biotech company Imclone Systems (Nasdaq: IMCL), where he is Chairman of the Board.
In early, 2008 Icahn activist target BEA Systems (Nasdaq: BEAS) was sold to Oracle (Nasdaq: ORCL). Icahn held a 13% stake in BEA.
Icahn is also involved with developments at Biogen Idec (Nasdaq: BIIB) and WCI Communities (NYSE: WCI), which both unsuccessfully explored sales. WCI rejected a $22 per share takeover offer from Icahn in early 2007, only to see its stock plummet on the housing slowdown.
In 2008, Icahn targeted Yahoo! (Nasdaq: YHOO) after the Internet company failed to work out an acceptable merger agreement with Microsoft (Nasdaq: MSFT) Microsoft walked away from its bid for Yahoo! after months of bickering.
View Older Stories View More Recent Stories
-
Unusual 11 Mid-Day Movers 4/17: DFR, REV, UIS, RAD Higher; LPS, CHP, CYT, MGM Lower
-
Morning Movers 4/17: DRYS, TEL, ICUI, MHP, TPX Higher; CYT, MGM, HNSN, MEG, AOS Lower
-
After-Hours Movers 4/16: TEL, DRYS, TPX, ICUI Higher; CYT, MGM, WRI, AMLN, BIIB Lower
-
Icahn and Oaktree Want to Push MGM Mirage (MGM) Into Bankruptcy
-
Carl Icahn, Oaktree Capital Push For MGM Mirage (MGM) Bankruptcy
-
Icahn Sends Letter to Amylin (AMLN): Demands Chairman's Resignation
-
Biogen Idec (BIIB) May volatility at 58; July at 51 into EPS and Icahn pressure
-
Biogen Idec (BIIB) Rises On Renewed Takeover Talk
-
Eastbourne Capital Sends Letter to Amylin (AMLN); Seeking 5 Seats on Board
-
Biogen (BIIB) Rejects Icahn's Proposals
-
Icahn Makes $200M Opening Bid for Tropicana Casino and Resort
-
Icahn Comments on Lions Gate (LGF) Comments Regarding Debt Offer
-
Lionsgate (LGF) Board Expresses No Opinion and Remains Neutral Toward Icahn's Unsolicited Debt Tender Offer
-
Icahn To Commence Tender Offer For Lions Gate (LGF) Notes
-
Carl Icahn's Protege Challenges Him On Lions Gate (LGF)
-
KeyBanc Upgrades Greenbrier (GBX) to Buy; GBX and ARII Most Likely Candidates for Some Sort of M&A Activity
-
Icahn Terminates Talks with Lions Gate (LGF)
-
Icahn Enterprises (IEP) Approves $0.25 Per Share Q1 Dividend
-
Top 10 News Items 2/17-2/20: Obama Unveils Housing Plan; Financials Continue Getting Smashed; GM Asks for Additional $4.5B
-
Icahn Raises Stakes In AMLN, LGF, WMB, YHOO; Cuts Stakes in TIN, LEA
-
Baird Downgrades Biogen Idec (BIIB) On Tysabri, Not Buying Takeover Talk
-
Icahn Seeks To Add Four To Biogen Idec's (BIIB) Board
-
Icahn Raises Stake Amylin Pharma (AMLN) To 9.4%
-
Amylin (AMLN) Has Investors Fired-Up for Change
-
Icahn Boosts Stake In Enzon (ENZN) to 7.8%
-
Like ImClone, Icahn Will Get Amylin (AMLN) Sold
-
Icahn Looks To Band Together Steel Partners Investors Against WebFinancial Solution
-
Icahn Won't Take Yahoo!/Microsoft Deal Off the Table
-
Icahn Not Interested In Partial Bid for Yahoo! (YHOO)
-
Analyst Sees Two More Steps Before A Microsoft/Yahoo Search Deal (MSFT, YHOO)
-
Reports New Microsoft/Yahoo Talks Are "Total Fiction"
-
Carl Icahn Boosts His Stake In Yahoo! (YHOO) By Nearly 7M Shares
-
Unusual 11 Mid-Day Movers 11/17: GTE, CTS, PHH, ARTG Higher; UTHR, DFT, BIDU, HIG Lower
-
AMD (AMD) Gets a Lift from New Icahn Stake, Cramer Tout
-
Carl Icahn shows new 800K share stake in Citi (C)
-
Carl Icahn shows new 1.6 million shares stake in AMD (AMD)
-
Carl Icahn Injects His Personal Money Into His Hedge Fund
-
Losses At Citadel And Other Hedge Funds Forces Market Lower
-
Eastbourne Capital May Talk With Amylin Pharma (AMLN) About A Possible Sale
-
More Executive Margin Calls--This Time At Lions Gate's Films (LGF)
-
Icahn Builds 9.17% Stake in Lions Gate (LGF); Says Shares Are Undervalued
-
More Comments from Carl Icahn from the Value Investing Congress
-
Icahn Says Boards Need To Be Held Accountable
-
Carl Icahn Speaking Now At Value Investing Congress--Doesn't Like Boards
-
Notable Mergers and Acquisitions of the Day 10/06: IMCL/LLY, VSH/IRF, EBAY
-
StreetInsider.com Reporting From Value Investing Congress Today
-
ImClone (IMCL) Enters Merger Agreement With Eli Lilly (LLY) For $70/Share
-
ImClone's (IMCL) Carl Icahn Issues Statement On Takeover Bid
-
Yahoo! (YHOO) Sees Interest On Rumor Microsoft Could Come Back To The Table
-
Yahoo!'s (YHOO) New Board Authorizes Fresh Talks With AOL
